Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
CME Cme Group Inc
- Stocks
- Financial Services
- NASDAQ: CME
Price (delayed)
$268.34
Market cap
$96.7B
P/E Ratio
26.91
Dividend/share
$10.5
EPS
$9.97
Enterprise value
$219.41B
CME Group Inc. is a global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals,
Highlights
The company's net income rose by 13% YoY and by 2.9% QoQ
The EPS is up by 13% year-on-year and by 2.9% since the previous quarter
The debt has grown by 27% year-on-year and by 21% since the previous quarter
CME's P/E is 13% above its last 4 quarters average of 23.8
Sector: Financial Services
Industry: Financial Data & Stock Exchanges
Website: https://www.cmegroup.com/
Key stats
What are the main financial stats of CME
Market
Valuations
Earnings
Shares outstanding
360.36M
Market cap
$96.7B
Enterprise value
$219.41B
Price to earnings (P/E)
26.91
Price to book (P/B)
3.58
Price to sales (P/S)
15.36
EV/EBIT
45.81
EV/EBITDA
42.82
EV/Sales
34.91
Revenue
$6.28B
Gross profit
$6.28B
Operating income
$4.08B
Net income
$3.58B
EBIT
$4.79B
EBITDA
$5.12B
Free cash flow
$3.83B
Per share
Balance sheet
Liquidity
EPS
$9.97
EPS diluted
$9.94
Free cash flow per share
$10.64
Book value per share
$75.01
Revenue per share
$17.48
TBVPS
$354.22
Total assets
$157.83B
Total liabilities
$130.8B
Debt
$124.11B
Equity
$27.03B
Working capital
$2.03B
Debt to equity
4.59
Current ratio
1.02
Quick ratio
1.01
Net debt/EBITDA
23.95
Margins
Efficiency
Dividend
EBITDA margin
81.5%
Gross margin
100%
Net margin
57%
Operating margin
64.9%
Return on assets
2.6%
Return on equity
13.1%
Return on invested capital
4.4%
Return on capital employed
13.2%
Return on sales
76.2%
Dividend yield
3.91%
DPS
$10.5
Payout ratio
105.3%
CME stock price
How has the Cme Group stock price performed over time
Intraday
-0.79%
1 week
-5.17%
1 month
2.6%
1 year
27.83%
YTD
15.55%
QTD
1.15%
Financial performance
How have Cme Group's revenue and profit performed over time
Revenue
$6.28B
Gross profit
$6.28B
Operating income
$4.08B
Net income
$3.58B
Gross margin
100%
Net margin
57%
The operating income is up by 17% YoY and by 3.8% QoQ
The company's net income rose by 13% YoY and by 2.9% QoQ
CME's revenue is up by 12% year-on-year and by 2.5% since the previous quarter
The gross profit has increased by 12% YoY and by 2.5% from the previous quarter
Price vs fundamentals
How does CME's price correlate with its fundamentals
Growth
What is Cme Group's growth rate over time
Valuation
What is Cme Group stock price valuation
P/E
26.91
P/B
3.58
P/S
15.36
EV/EBIT
45.81
EV/EBITDA
42.82
EV/Sales
34.91
CME's P/E is 13% above its last 4 quarters average of 23.8
The EPS is up by 13% year-on-year and by 2.9% since the previous quarter
CME's price to book (P/B) is 33% higher than its 5-year quarterly average of 2.7 and 19% higher than its last 4 quarters average of 3.0
The equity has grown by 2.1% since the previous quarter
The P/S is 14% higher than the last 4 quarters average of 13.5 and 10% higher than the 5-year quarterly average of 14.0
CME's revenue is up by 12% year-on-year and by 2.5% since the previous quarter
Efficiency
How efficient is Cme Group business performance
Cme Group's return on equity has increased by 14% YoY and by 3.1% QoQ
Cme Group's return on assets has increased by 13% YoY
The ROIC has grown by 7% YoY but it has contracted by 4.3% from the previous quarter
Dividends
What is CME's dividend history
DPS
$10.5
Dividend yield
3.91%
Payout ratio
105.3%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Cme Group financials performed over time
Cme Group's total assets is 21% more than its total liabilities
Cme Group's total liabilities has increased by 25% YoY and by 18% QoQ
Cme Group's total assets has increased by 20% YoY and by 15% from the previous quarter
The debt to equity has grown by 27% YoY and by 19% from the previous quarter
The debt has grown by 27% year-on-year and by 21% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.